Results 121 to 130 of about 22,552 (237)
A third international survey to study clinical laboratory testing for the lupus anticoagulant
Lupus anticoagulants (LA) are immunoglobulins (IgG, IgM, IgA or a mixture) that interfere with in vitro phospholipids (PL) dependent coagulation tests.
Barna, Linda K.
core
Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies.
Lupus anticoagulant and antiphospholipid antibodies are associated with thromboembolic phenomena in individuals both with and without systemic lupus erythematosus.
D Brunet +3 more
core +1 more source
Thrombophilia in children with diffuse connective tissue disorders as systemic lupus erythematosus (SLE) and juvenile dermatomyositis (JDM) could arise from various causes including peripherial blood circulation of antiphospholipid antibodies (APH) and ...
O.A. Solntseva
doaj +2 more sources
Lupus Anticoagulant Detection under the Magnifying Glass. [PDF]
Molinari AC +6 more
europepmc +1 more source
Autontibodies to a wide variety of antigens are associated with systemic lupus erythematosus (SLE) and the Antiphospholipid Syndrome (APS).
Lambrianides, A.
core
Lupus anticoagulant and bilateral optic disc edema: a case report.
We present the case of a 29-year-old woman with the rare combination of lupus anticoagulant and bilateral optic disc edema.
Formicola R. +4 more
core
Ischemic Pituitary Apoplexy Associated with Lupus Anticoagulant
The lupus anticoagulant (LA) is one of the antiphospholipid antibodies (aPL) that belongs to a heterogeneous family of autoantibodies. LA prolongs the phospholipid-dependent coagulation assay and is more specific but less sensitive for patients at risk ...
Jennifer A. Galvin, MD; Gregory P. Van Stavern, MD
core
Ninety-one consecutive patients with systemic lupus erythematosus (SLE) were studied. Forty-two patients had positive anticardiolipin antibodies (aCl) 40 aCl-IgG (44.4%); 4 aCl-IgA (4.4%); 1 aCl-IgM (1.1%). One patient had both a Cl-IgG and aCl-IgA and 1
Chan, Kwokhung +4 more
core
Lupus anticoagulant hypoprothrombinemia syndrome successfully treated with rituximab - case report. [PDF]
Iarossi M +5 more
europepmc +1 more source
Lupus anticoagulant hypoprothrombinemia syndrome - could it be a sequelae of COVID-19? [PDF]
Matijasic Stjepovic N +3 more
europepmc +1 more source

